INNOVIVA INC (INVA) Fundamental Analysis & Valuation

NASDAQ:INVA • US45781M1018

Current stock price

21.7 USD
-0.39 (-1.77%)
At close:
21.7 USD
0 (0%)
After Hours:

This INVA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. INVA Profitability Analysis

1.1 Basic Checks

  • INVA had positive earnings in the past year.
  • INVA had a positive operating cash flow in the past year.
  • Each year in the past 5 years INVA has been profitable.
  • Each year in the past 5 years INVA had a positive operating cash flow.
INVA Yearly Net Income VS EBIT VS OCF VS FCFINVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 16.58%, INVA belongs to the top of the industry, outperforming 95.34% of the companies in the same industry.
  • With an excellent Return On Equity value of 23.12%, INVA belongs to the best of the industry, outperforming 92.75% of the companies in the same industry.
  • INVA's Return On Invested Capital of 7.51% is amongst the best of the industry. INVA outperforms 84.97% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for INVA is below the industry average of 12.98%.
Industry RankSector Rank
ROA 16.58%
ROE 23.12%
ROIC 7.51%
ROA(3y)10.94%
ROA(5y)15.78%
ROE(3y)17.71%
ROE(5y)31.01%
ROIC(3y)8.6%
ROIC(5y)13.83%
INVA Yearly ROA, ROE, ROICINVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200

1.3 Margins

  • With an excellent Profit Margin value of 65.92%, INVA belongs to the best of the industry, outperforming 97.93% of the companies in the same industry.
  • In the last couple of years the Profit Margin of INVA has remained more or less at the same level.
  • INVA has a Operating Margin of 39.81%. This is amongst the best in the industry. INVA outperforms 97.93% of its industry peers.
  • INVA's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 74.80%, INVA belongs to the top of the industry, outperforming 81.87% of the companies in the same industry.
  • In the last couple of years the Gross Margin of INVA has declined.
Industry RankSector Rank
OM 39.81%
PM (TTM) 65.92%
GM 74.8%
OM growth 3Y-13.95%
OM growth 5Y-16.03%
PM growth 3Y0.7%
PM growth 5Y-0.21%
GM growth 3Y-7.93%
GM growth 5YN/A
INVA Yearly Profit, Operating, Gross MarginsINVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50 100 150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. INVA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), INVA is destroying value.
  • INVA has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for INVA has been reduced compared to 5 years ago.
  • INVA has a better debt/assets ratio than last year.
INVA Yearly Shares OutstandingINVA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
INVA Yearly Total Debt VS Total AssetsINVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 3.40 indicates that INVA is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.40, INVA is in the better half of the industry, outperforming 69.95% of the companies in the same industry.
  • INVA has a debt to FCF ratio of 1.38. This is a very positive value and a sign of high solvency as it would only need 1.38 years to pay back of all of its debts.
  • INVA has a better Debt to FCF ratio (1.38) than 95.34% of its industry peers.
  • INVA has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.22, INVA perfoms like the industry average, outperforming 43.01% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.38
Altman-Z 3.4
ROIC/WACC0.85
WACC8.87%
INVA Yearly LT Debt VS Equity VS FCFINVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • INVA has a Current Ratio of 14.64. This indicates that INVA is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 14.64, INVA belongs to the best of the industry, outperforming 86.53% of the companies in the same industry.
  • INVA has a Quick Ratio of 13.85. This indicates that INVA is financially healthy and has no problem in meeting its short term obligations.
  • INVA has a better Quick ratio (13.85) than 86.01% of its industry peers.
Industry RankSector Rank
Current Ratio 14.64
Quick Ratio 13.85
INVA Yearly Current Assets VS Current LiabilitesINVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. INVA Growth Analysis

3.1 Past

  • INVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1505.26%, which is quite impressive.
  • The Earnings Per Share has been growing by 8.59% on average over the past years. This is quite good.
  • Looking at the last year, INVA shows a quite strong growth in Revenue. The Revenue has grown by 14.67% in the last year.
  • INVA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.08% yearly.
EPS 1Y (TTM)1505.26%
EPS 3Y11.17%
EPS 5Y8.59%
EPS Q2Q%646.15%
Revenue 1Y (TTM)14.67%
Revenue growth 3Y7.48%
Revenue growth 5Y4.08%
Sales Q2Q%24.84%

3.2 Future

  • INVA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.11% yearly.
  • INVA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.69% yearly.
EPS Next Y-34.18%
EPS Next 2Y-15.45%
EPS Next 3Y-12.55%
EPS Next 5Y21.11%
Revenue Next Year10.03%
Revenue Next 2Y11.33%
Revenue Next 3Y8.64%
Revenue Next 5Y5.69%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
INVA Yearly Revenue VS EstimatesINVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M 500M
INVA Yearly EPS VS EstimatesINVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

8

4. INVA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 7.11, which indicates a rather cheap valuation of INVA.
  • 93.78% of the companies in the same industry are more expensive than INVA, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of INVA to the average of the S&P500 Index (25.23), we can say INVA is valued rather cheaply.
  • A Price/Forward Earnings ratio of 10.81 indicates a reasonable valuation of INVA.
  • Based on the Price/Forward Earnings ratio, INVA is valued cheaper than 85.49% of the companies in the same industry.
  • INVA is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.28, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.11
Fwd PE 10.81
INVA Price Earnings VS Forward Price EarningsINVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INVA indicates a rather cheap valuation: INVA is cheaper than 95.34% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, INVA is valued cheaper than 92.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.62
EV/EBITDA 6.29
INVA Per share dataINVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • INVA has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as INVA's earnings are expected to decrease with -12.55% in the coming years.
PEG (NY)N/A
PEG (5Y)0.83
EPS Next 2Y-15.45%
EPS Next 3Y-12.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. INVA Dividend Analysis

5.1 Amount

  • INVA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INVA Fundamentals: All Metrics, Ratios and Statistics

INNOVIVA INC

NASDAQ:INVA (3/20/2026, 8:01:56 PM)

After market: 21.7 0 (0%)

21.7

-0.39 (-1.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners106.59%
Inst Owner Change-2.1%
Ins Owners1.08%
Ins Owner Change3.42%
Market Cap1.61B
Revenue(TTM)411.33M
Net Income(TTM)271.17M
Analysts81.82
Price Target33.66 (55.12%)
Short Float %9.08%
Short Ratio9.09
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)182.63%
Min EPS beat(2)119.45%
Max EPS beat(2)245.81%
EPS beat(4)3
Avg EPS beat(4)16.52%
Min EPS beat(4)-350.17%
Max EPS beat(4)245.81%
EPS beat(8)4
Avg EPS beat(8)-27.73%
EPS beat(12)7
Avg EPS beat(12)20.38%
EPS beat(16)8
Avg EPS beat(16)-23.72%
Revenue beat(2)2
Avg Revenue beat(2)12.62%
Min Revenue beat(2)9.49%
Max Revenue beat(2)15.75%
Revenue beat(4)4
Avg Revenue beat(4)9.29%
Min Revenue beat(4)5.11%
Max Revenue beat(4)15.75%
Revenue beat(8)8
Avg Revenue beat(8)12.23%
Revenue beat(12)11
Avg Revenue beat(12)11.26%
Revenue beat(16)12
Avg Revenue beat(16)1.54%
PT rev (1m)1.54%
PT rev (3m)2.33%
EPS NQ rev (1m)-6.02%
EPS NQ rev (3m)-6.02%
EPS NY rev (1m)-8.14%
EPS NY rev (3m)-8.14%
Revenue NQ rev (1m)1.23%
Revenue NQ rev (3m)1.21%
Revenue NY rev (1m)1.62%
Revenue NY rev (3m)1.58%
Valuation
Industry RankSector Rank
PE 7.11
Fwd PE 10.81
P/S 3.91
P/FCF 8.62
P/OCF 8.16
P/B 1.37
P/tB 1.75
EV/EBITDA 6.29
EPS(TTM)3.05
EY14.06%
EPS(NY)2.01
Fwd EY9.25%
FCF(TTM)2.52
FCFY11.6%
OCF(TTM)2.66
OCFY12.25%
SpS5.55
BVpS15.83
TBVpS12.38
PEG (NY)N/A
PEG (5Y)0.83
Graham Number32.96
Profitability
Industry RankSector Rank
ROA 16.58%
ROE 23.12%
ROCE 10.33%
ROIC 7.51%
ROICexc 11.69%
ROICexgc 15.62%
OM 39.81%
PM (TTM) 65.92%
GM 74.8%
FCFM 45.32%
ROA(3y)10.94%
ROA(5y)15.78%
ROE(3y)17.71%
ROE(5y)31.01%
ROIC(3y)8.6%
ROIC(5y)13.83%
ROICexc(3y)12.83%
ROICexc(5y)19.03%
ROICexgc(3y)20.63%
ROICexgc(5y)28.4%
ROCE(3y)11.81%
ROCE(5y)19.01%
ROICexgc growth 3Y-23.7%
ROICexgc growth 5Y-16.1%
ROICexc growth 3Y-14.48%
ROICexc growth 5Y-17.86%
OM growth 3Y-13.95%
OM growth 5Y-16.03%
PM growth 3Y0.7%
PM growth 5Y-0.21%
GM growth 3Y-7.93%
GM growth 5YN/A
F-Score5
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.38
Debt/EBITDA 1.26
Cap/Depr 26.1%
Cap/Sales 2.55%
Interest Coverage 15.82
Cash Conversion 96.55%
Profit Quality 68.75%
Current Ratio 14.64
Quick Ratio 13.85
Altman-Z 3.4
F-Score5
WACC8.87%
ROIC/WACC0.85
Cap/Depr(3y)12.65%
Cap/Depr(5y)7.7%
Cap/Sales(3y)1.29%
Cap/Sales(5y)0.78%
Profit Quality(3y)311.8%
Profit Quality(5y)233.29%
High Growth Momentum
Growth
EPS 1Y (TTM)1505.26%
EPS 3Y11.17%
EPS 5Y8.59%
EPS Q2Q%646.15%
EPS Next Y-34.18%
EPS Next 2Y-15.45%
EPS Next 3Y-12.55%
EPS Next 5Y21.11%
Revenue 1Y (TTM)14.67%
Revenue growth 3Y7.48%
Revenue growth 5Y4.08%
Sales Q2Q%24.84%
Revenue Next Year10.03%
Revenue Next 2Y11.33%
Revenue Next 3Y8.64%
Revenue Next 5Y5.69%
EBIT growth 1Y-1.87%
EBIT growth 3Y-7.52%
EBIT growth 5Y-12.6%
EBIT Next Year60.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1.09%
FCF growth 3Y-2.57%
FCF growth 5Y-9.85%
OCF growth 1Y4.37%
OCF growth 3Y-0.79%
OCF growth 5Y-8.86%

INNOVIVA INC / INVA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INNOVIVA INC?

ChartMill assigns a fundamental rating of 7 / 10 to INVA.


Can you provide the valuation status for INNOVIVA INC?

ChartMill assigns a valuation rating of 8 / 10 to INNOVIVA INC (INVA). This can be considered as Undervalued.


What is the profitability of INVA stock?

INNOVIVA INC (INVA) has a profitability rating of 7 / 10.


What is the earnings growth outlook for INNOVIVA INC?

The Earnings per Share (EPS) of INNOVIVA INC (INVA) is expected to decline by -34.18% in the next year.


How sustainable is the dividend of INNOVIVA INC (INVA) stock?

The dividend rating of INNOVIVA INC (INVA) is 0 / 10 and the dividend payout ratio is 0%.